Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genomic instability in bone marrow failure syndromes.

William G Kearns1, Joanne F Sutton, Jaroslaw P Maciejewski

  • 1Hematology Branch, National Heart, Lung, & Blood Institute/NIH, Building 10, Room 7C103, Bethesda, MD, USA.

American Journal of Hematology
|June 30, 2004
PubMed
Summary

Undetected aneuploidy, specifically monosomy 7 or trisomy 8, is common in bone marrow failure syndromes. Fluorescence in situ hybridization (FISH) revealed these abnormalities, impacting patient outcomes and disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

Blood cancer journal·2026
Same author

Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee.

The Lancet. Haematology·2026
Same author

Lessons of nature from trisomy-8 myeloid neoplasia: the riddle of oncogenic clonal drives.

Haematologica·2026
Same author

High-resolution single-cell mapping of clonal hematopoiesis and structural variation in aplastic anemia.

Nature genetics·2026
Same author

Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in <i>KMT2A</i>r and <i>NPM1</i>-m AML.

bioRxiv : the preprint server for biology·2026
Same author

Validation of ICC hierarchical classification in secondary AML.

Blood advances·2026

Area of Science:

  • Hematology
  • Cytogenetics
  • Molecular Biology

Background:

  • Aneuploidy is common in leukemia and myelodysplastic syndromes (MDS).
  • Aneuploidy was previously considered rare in aplastic anemia (AA).
  • Bone marrow failure syndromes encompass a range of hematologic disorders.

Purpose of the Study:

  • To determine the frequency of undetected aneuploidy for chromosomes 7 and 8 in bone marrow failure syndromes.
  • To compare fluorescence in situ hybridization (FISH) with routine cytogenetic analysis for detecting aneuploidy.
  • To investigate the clinical significance of undetected aneuploidy in these conditions.

Main Methods:

  • Examined marrow cells from 96 unselected patients with bone marrow failure syndromes.
  • Utilized fluorescence in situ hybridization (FISH) to detect aneuploidy for chromosomes 7 and 8.

Related Experiment Videos

  • Compared FISH results with routine cytogenetic analysis.

    • Main Results:

    • Twenty-eight percent (27/96) of patients showed abnormal karyotypes via routine analysis.
    • FISH identified an additional 27 patients with undetected monosomy 7 or trisomy 8.
    • Patients with undetected monosomy 7 exhibited poor clinical outcomes, including treatment resistance and early mortality.

    Conclusions:

    • A significant percentage of patients with bone marrow failure syndromes harbor undetected aneuploidy in their marrow cells.
    • FISH is a valuable tool for detecting aneuploidy missed by conventional cytogenetics.
    • Undetected aneuploidy, particularly monosomy 7, is associated with adverse clinical outcomes and disease progression.